[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353367-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353367-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumor-microenvironment-responsive-nanoparticles-for-pancreatic-cancer-imaging-and-treatment","Tumor Microenvironment-Responsive Nanoparticles for Pancreatic Cancer Imaging and Treatment","","Early diagnosis and effective treatment of pancreatic cancer remain major clinical challenges, given its aggressive, lethal nature. The tumor microenvironment (TME) shows high interstitial fluid pressure, abnormal vasculature, hypoxia, acidosis, and excess reactive oxygen species, promoting progression and immunosuppression while reducing diagnostic and therapeutic efficiency. TME is therefore a key theranostic target. Nanoparticles are promising for bio-imaging and targeted drug delivery; the review summarizes TME-transforming NP designs and performances and highlights translational obstacles.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumor-microenvironment-responsive-nanoparticles-for-pancreatic-cancer-imaging-and-treatment/353367/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumor-microenvironment-responsive-nanoparticles-for-pancreatic-cancer-imaging-and-treatment/353367.png","ImageObject",300,407,{"name":42,"@type":43},"nayy☆","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes the tumor microenvironment (TME) important in pancreatic cancer?","Question",{"text":63,"@type":64},"The TME in pancreatic cancer has features such as high interstitial fluid pressure, abnormal vessels, hypoxia, acidosis, and elevated reactive oxygen species that drive tumor progression and immunosuppression while lowering diagnostic and treatment efficiency.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is early diagnosis of pancreatic cancer difficult?",{"text":68,"@type":64},"Early-stage pancreatic cancer often lacks specific symptoms, leading to missed or incorrect diagnosis. Even when symptoms emerge, most patients are already in later stages, limiting the proportion eligible for surgical resection.",{"name":70,"@type":61,"acceptedAnswer":71},"How do TME-transforming nanoparticles aim to improve care?",{"text":72,"@type":64},"Nanoparticles are designed to support bio-imaging and targeted drug delivery by adapting to or transforming features of the TME, with the goal of improving both diagnostic efficiency and treatment efficacy. The review also notes obstacles that must be overcome before clinical translation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353367,1790196248,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":97,"preview_urls":146},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","International Journal of Nanomedicine  \n Open Access Full Text Article  \nREVIEW  \nTumor Microenvironment-Responsive Nanoparticles for Pancreatic Cancer Imaging and Treatment  \nWenli Qiu 1 , Jinghong Li 1 , Yingying Cao 1 , Hongguang Zhou2 , Hui Hu 1 , Zhongqiu Wang 1  \n1Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, People’s Republic of China; 2Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, People’s Republic of China  \nCorrespondence: Hui Hu; Zhongqiu Wang, Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, People’s Republic of China, Tel/Fax +86025-85811065, Email [huhui2206@163.com](huhui2206@163.com); [zhq200105@sina.com](zhq200105@sina.com)  \n\n| Abstract: Early diagnosis and effective treatment of pancreatic cancer remain major clinical challenges, one of the most aggressive and lethal tumors. The tumor microenvironment (TME) in pancreatic cancer exhibits unique features, including high interstitial fluid pressure (IFP), abnormal blood vessels, hypoxia, acidosis, and excess reactive oxygen species (ROS), all favoring tumor progression and immunosuppression, meanwhile offsetting diagnostic efficiency and treatment efficacy. Thus, the TME of pancreatic cancer is considered as a target of profound theranostic significance. Nanoparticles (NPs) have shown a high profile in bio-imaging and targeted drug delivery. Here, we depicted the TME of pancreatic cancer and reviewed the designs and performances of TME-transforming NPsin the diagnosis and treatment of pancreatic cancer, as well as the obstacles to be overcome before their clinical translation. This review is expected to provide sparks for the early diagnosis and personalized treatment for pancreatic cancer.\u003Cbr>Keywords: tumor microenvironment, nanoparticles, pancreatic cancer, imaging, treatment |\n| --- |\n| Introduction\u003Cbr>Pancreatic cancer, the most aggressive and lethal tumor, develops as normal glandular epithelium differentiates into precursor lesions and ultimately invasive cancer, with an overall 5-year survival rate about 13% worldwide.1 Among them, approximately 95% of tumors arise from pancreatic intraepithelial neoplasias (panINs) (Figure 1) .2 In the early stage, it usually presents no specific symptoms, but only mild abdominal bloating and loss of appetite, which often leads to missed or wrong diagnosis; upon the appearance of typical symptoms, such as jaundice, severe abdominal pain, and rapid weight loss, the disease has progressed to the late stage. Therefore, only 15–20% of patients diagnosed with early pancreatic cancer are eligible for surgical resection,3 which can increase the 5-year survival rate to 15–25%; however, the recurrence rate after resection is as high as 85%, and the overall prognosis remains dismal.4 Therefore, new approaches are still needed for the early diagnosis and effective treatment of pancreatic cancer.\u003Cbr>Despite their limited specificity and sensitivity, laboratory tests and imaging examinations remain conventional in the diagnosis, monitoring, and follow-up of pancreatic cancer.5–7 In laboratory tests, serum carbohydrate antigen (CA) 19–9 is routinely measured, but its relatively low specificity and sensitivity restrain its single use in early screening and diagnosis of pancreatic cancer.8,9 Current diagnostic imaging methods mainly include ultrasound (US), computed tomography (CT), and magnetic resonance (MR) .10 These methods can display some morphological changes in pancreatic tissue, but each has its limitations in spatial resolution, imaging depth, and sensitivity. For example, EUScan detect lesions with a diameter as short as 2–3 mm, but its accuracy heavily depends on the experience of operator, and drops in a limited field of view.11, 12 CT is not sensitive enough for lesions smaller than 1 cm in diameter, and may miss diagnoses.13, 14 MRI examination can b","cbCairrQlAay9zCY","https://ap.wps.com/l/cbCairrQlAay9zCY","pdf",26801491,43,"English","# Introduction\n## Clinical challenges in early diagnosis and treatment\n## Limitations of current diagnostic tools\n## Treatment advances and unmet needs\n## Role of pancreatic cancer TME and theranostic potential\n## Nanoparticles in imaging and targeted delivery","[{\"question\":\"What makes the tumor microenvironment (TME) important in pancreatic cancer?\",\"answer\":\"The TME in pancreatic cancer has features such as high interstitial fluid pressure, abnormal vessels, hypoxia, acidosis, and elevated reactive oxygen species that drive tumor progression and immunosuppression while lowering diagnostic and treatment efficiency.\"},{\"question\":\"Why is early diagnosis of pancreatic cancer difficult?\",\"answer\":\"Early-stage pancreatic cancer often lacks specific symptoms, leading to missed or incorrect diagnosis. Even when symptoms emerge, most patients are already in later stages, limiting the proportion eligible for surgical resection.\"},{\"question\":\"How do TME-transforming nanoparticles aim to improve care?\",\"answer\":\"Nanoparticles are designed to support bio-imaging and targeted drug delivery by adapting to or transforming features of the TME, with the goal of improving both diagnostic efficiency and treatment efficacy. The review also notes obstacles that must be overcome before clinical translation.\"}]","Tumor Microenvironment-Responsive Nanoparticles for Pancreatic Cancer Imaging and Treatment | PDF",1790104917,108,[147,151,155,159,163],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef3d4adf96934ca68814cd71a148664d.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/039a0e9fead7fce4a05b2c175ee57cef.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/881f93d3864fe8b609cd406698663f40.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee02ce3720344842766de5f2702630bf.webp",980,1268,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e1d820413fd6ead6189ed86b349c4b4.webp",979,1267]